InsiderTrades.com logo
The solution to fast food’s wage hike crisis
From Deal Maker   |   Ad
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
Learn more about this much-needed advancement and investment opportunity here.

ARTV Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $29,999,976.00
Insider Selling (Last 12 Months): $0.00

Artiva Biotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Artiva Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Artiva Biotherapeutics Share Price & Price History

Current Price: $12.02
Price Change: ▲ Price Increase of +0.11 (0.92%)
As of 09/6/2024 01:00 AM ET

This chart shows the closing price history over time for ARTV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.

Artiva Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/22/2024Global Strategic Fund I VenbioMajor ShareholderBuy416,666$12.00$4,999,992.001,936,637View SEC Filing Icon  
7/22/2024Yong-Jun HuhDirectorBuy2,083,332$12.00$24,999,984.003,306,900View SEC Filing Icon  
See Full Table
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
From Mode Mobile   |   Ad
45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.
Claim Exclusive 100% Bonus: $0.25/Share

SEC Filings (Institutional Ownership Changes) for Artiva Biotherapeutics (NASDAQ:ARTV)

Artiva Biotherapeutics logo
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell product candidate; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate. The company was incorporated in 2019 and is headquartered in San Diego, California.
Read More on Artiva Biotherapeutics

Today's Range

Now: $12.02
Low: $11.71
High: $12.05

50 Day Range

MA: N/A

52 Week Range

Now: $12.02
Low: $9.71
High: $16.00

Volume

65,745 shs

Average Volume

110,337 shs

Market Capitalization

$279.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Artiva Biotherapeutics?

Artiva Biotherapeutics' top insider investors include:
  1. Yong-Jun Huh (Director)
  2. Global Strategic Fund I Venbio (Major Shareholder)
Learn More about top insider investors at Artiva Biotherapeutics.
The solution to fast food’s wage hike crisis
From Deal Maker   |   Ad
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
Learn more about this much-needed advancement and investment opportunity here.